Pfizer (PFE) Closes Last Hour Down $-0.27; in a Downtrend Over Past 30 Days, Heads Down For the 2nd Consecutive Day

The Hourly View for PFE

Last Updated September 16, 2020, 23:11 GMT

Currently, PFE’s price is up $0.04 (0.11%) from the hour prior. This is a reversal of the price action on the previous hour, in which price moved up. As for the trend on the hourly timeframe, we see the clearest trend on the 50 hour timeframe. Most noteworthy in the world of moving averages on the hourly chart is that the 100 and 20 hour moving averages have been crossed, so that price is now turning below them. The moving averages on the hourly timeframe suggest a choppiness in price, as the 20, 50 and 100 are all in a mixed alignment — meaning the trend across timeframes is inconsistent, indicating a potential opportunity for rangebound traders.

Pfizer Inc Daily Price Recap

Pfizer Inc came into today down 0.49% ($0.18) from the open of yesterday, marking the 2nd consecutive day a decline has happened. The price move occurred on volume that was up 0.05% from the day prior, but down 18.07% from the same day the week before. Let’s take a look at the daily price chart of Pfizer Inc.


Pfizer Inc Technical Analysis

Notably, Pfizer Inc is now close to its 20, 50, 100 and 200 day averages, located at 37.31, 37.31, 36.59 and 36.49 respectively, and thus may be at a key juncture along those timeframes. The clearest trend exists on the 30 day timeframe, which shows price moving down over that time. Or to view things another way, note that out of the past 10 days Pfizer Inc’s price has gone down 6 them.

Overheard Around the Web

Over on StockTwits, here’s an example of what they’re saying about PFE:


    I hope everyone is paying attention here? Between Trump and the CDC there is some serious reading between the lines needed.

    CNN are confused because they are too fixated on proving Trump wrong. It's insane how obsessed they are.

    All the above covid plays have potential to work. It's not about being first here, read between the lines.

    My money is on $NVAX taking the top medal, but I see no reason why any of the above (pending successful data results) will fail in the long term. Keep an eye on those results and good luck to all.

    Anyone who thinks it's about "being first" is not understanding the main game on this now.